ArticleInfectious diseases and therapy2025

Evolution of Self-reported Neuropsychiatric Symptoms After Switching from Dolutegravir/Abacavir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide: Results from the Randomized DOBINeuro Trial.

Barbara Rossetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.